Jehng-Kang Wang | Controlled Drug Delivery For Dermatology | Best Innovator Award

Posted on by Skincare

Prof. Jehng-Kang Wang | Controlled Drug Delivery For Dermatology | Best Innovator Award

National Defense Medical University | Taiwan

Prof. Jehng-Kang Wang currently serves as a senior researcher at the National Defense Medical University, Taiwan, where he is recognized for advancing the fields of biomedical science and controlled drug-delivery systems with a focus on dermatology and epithelial biology. Trained through a rigorous academic path that includes foundational studies in molecular and cellular sciences, he has established a research portfolio centered on protease regulation, glycosylation pathways, epithelial barrier function, and innovative therapeutic delivery mechanisms. His scholarly contributions include 49 peer-reviewed publications, collectively cited 1,098 times, with an h-index of 19, underscoring the durable impact of his work across dermatology, molecular genetics, and translational biomedical research. Publication highlights include influential studies on HAI-1 and HAI-2 signaling, protein-folding–associated skin disorders, and emerging drug-delivery methods aimed at improving therapeutic precision in dermatologic and systemic diseases. Prof. Wang has collaborated with more than 170 co-authors globally, demonstrating his active role in interdisciplinary scientific networks, and his research has contributed to improved understanding of skin-related protease pathways and their implications for disease mechanisms. Over the course of his career, he has contributed to several academic committees and has been invited to review manuscripts for specialized journals in cellular biology, dermatology, and biochemical science, reflecting his standing as a subject-matter expert. His work continues to support the development of safer, more effective, and biologically informed therapeutic strategies, with societal impact extending to improved diagnostics and treatment approaches for skin disorders and barrier-compromised conditions. Prof. Wang’s growing body of work positions him as a leading figure in biologically driven innovation for future dermatologic drug-delivery technologies.

Profile: Scopus

Featured Publications

1. Wang, J. K., Teng, I. J., Lo, T. J., Moore, S., Yeo, Y. H., Teng, Y. C., Kaul, M., Chen, C. C., Zuo, A. H., Chou, F. P., Yang, X., Tseng, I. C., Johnson, M. D., & Lin, C. Y. (2014). Matriptase autoactivation is tightly regulated by the cellular chemical environment. PLoS One.

2. Chang, H. D., Xu, Y., Lai, H., Yang, X., Tseng, C. C., Lai, Y. J., Pan, Y., Zhou, E., Johnson, M. D., Wang, J. K., & Lin, C. Y. (2015). Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells. PLoS One.

3. Lai, Y. J., Chang, H. H., Lai, H., Xu, Y., Shiao, F., Huang, N., Li, L., Lee, M. S., Johnson, M. D., Wang, J. K., & Lin, C. Y. (2015). N-glycan branching affects the subcellular distribution of and inhibition of matriptase by HAI-2/placental bikunin. PLoS One.

4. Lai, C. H., Lai, Y. J., Chou, F. P., Chang, H. H., Tseng, C. C., Johnson, M. D., Wang, J. K., & Lin, C. Y. (2016). Matriptase complexes and prostasin complexes with HAI-1 and HAI-2 in human milk: Significant proteolysis in lactation. PLoS One.

5. Chen, C. Y., Chen, C. J., Lai, C. H., Wu, B. Y., Lee, S. P., Johnson, M. D., Lin, C. Y., & Wang, J. K. (2016). Increased matriptase zymogen activation by UV irradiation protects keratinocyte from cell death. Journal of Dermatological Science.

.

Syed Haroon Khalid | Regenerative Skin Therapies | Editorial Board Member

Posted on by Skincare

Assist. Prof. Dr. Syed Haroon Khalid | Regenerative Skin Therapies | Editorial Board Member

Senior Lecturer | Universiti Teknologi Mara | Malaysia

Dr. Syed Haroon Khalid is a distinguished researcher and academic currently affiliated with Universiti Teknologi MARA (UiTM), Shah Alam, Malaysia, where he has established himself as a leading contributor in his field. With an impressive scholarly record, Dr. Khalid has authored 123 scientific publications, which have collectively garnered 1,675 citations from 1,496 citing documents, reflecting his substantial influence on global research communities. His h-index of 23 further demonstrates the sustained impact and relevance of his work across diverse thematic areas. Throughout his career, Dr. Khalid has collaborated extensively with both national and international researchers, engaging with over 330 co-authors, which highlights his commitment to interdisciplinary partnerships and knowledge exchange. His research contributions span multiple domains, supported by consistent publication output in reputable journals indexed in major scientific databases. He has also contributed to preprint research dissemination, reinforcing his dedication to early knowledge sharing and open scientific dialogue. Dr. Khalid’s academic work exhibits a strong orientation toward advancing applied and theoretical understanding within his specialization. His publications reflect methodological rigor, innovative approaches, and relevance to contemporary scientific challenges. The breadth of his collaborations and citation footprint underscores his role as a respected voice in his discipline, whose research continues to inform future studies and shape scholarly discourse. Beyond research productivity, Dr. Khalid’s scholarly achievements demonstrate meaningful societal impact. His work collectively contributes to scientific advancement, capacity building, and the development of solutions that address real-world issues. His active engagement within the academic community and sustained contributions over the years position him as an influential researcher with a growing global profile. Dr. Syed Haroon Khalid’s career exemplifies academic excellence, international collaboration, and a strong commitment to impactful scholarship, making him a valuable contributor to the advancement of science and higher education.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Syed, H. K., Liew, K. B., Loh, G. O. K., & Peh, K. K. (2015). Stability indicating HPLC–UV method for detection of curcumin in Curcuma longa extract and emulsion formulation. Food Chemistry.

2.  Mahmood, H., Khan, I. U., Asif, M., Khan, R. U., Asghar, S., Khalid, I., Khalid, S. H., … (2021). In vitro and in vivo evaluation of gellan gum hydrogel films: Assessing the co-impact of therapeutic oils and ofloxacin on wound healing. International Journal of Biological Macromolecules.

3. Khalid, S. H., Qadir, M. I., Massud, A., Ali, M., & Rasool, M. H. (2009). Effect of degree of cross-linking on swelling and drug release behaviour of poly (methyl methacrylate-co-itaconic acid) hydrogels for site-specific drug delivery. Journal of Drug Delivery Science and Technology

4. Hussain, A., Khalid, S. H., Qadir, M. I., Massud, A., Ali, M., Khan, I. U., Saleem, M., … (2011). Water uptake and drug release behaviour of methyl methacrylate-co-itaconic acid hydrogels cross-linked with methylene bis-acrylamide. Journal of Drug Delivery Science and Technology.

5. Mehmood, Y., Khan, I. U., Shahzad, Y., Khalid, S. H., Asghar, S., Irfan, M., Asif, M., … (2019). Facile synthesis of mesoporous silica nanoparticles using modified sol-gel method: Optimization and in vitro cytotoxicity studies. Pakistan Journal of Pharmaceutical Sciences.

Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Posted on by Skincare

Prof. Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Associate Professor of Medical Bacteriology | Shahed University | Iran

Dr. Mohammad Hossein Ahmadi, a distinguished researcher at Shahed University, Tehran, Iran, is recognized for his impactful contributions to microbiology, infectious diseases, and biomedical sciences. He holds advanced academic training in biological and medical sciences, complemented by extensive research experience that spans cellular studies, antimicrobial resistance, and innovative therapeutic materials. Dr. Ahmadi’s research primarily focuses on antibacterial mechanisms, carbapenem-resistant pathogens, mesenchymal stem cell applications, wound-healing biomaterials, and clinical microbiology, positioning him at the forefront of efforts to address global challenges related to drug-resistant infections. Over his career, he has authored 28 peer-reviewed publications, which have collectively attracted over 297 citations, earning him an h-index of 9, reflecting both productivity and scholarly influence. His recent works—including studies on the antibacterial potential of BM-MSCs encapsulated in collagen–fibrin hydrogels and analyses of the global prevalence of carbapenem-resistant Pseudomonas aeruginosa—demonstrate his commitment to translational research with clear clinical and societal benefits. Dr. Ahmadi has collaborated with more than 50 international co-authors, highlighting his strong interdisciplinary and cross-institutional engagement. His research has contributed to advancing knowledge in infection control, biomaterials engineering, and public health, with widespread relevance to clinicians, biomedical researchers, and health-policy stakeholders. Although primarily dedicated to research, he also supports the scientific community through peer-review activities and participation in scholarly dissemination. Dr. Ahmadi’s work continues to influence emerging strategies for combating antibiotic-resistant infections and improving therapeutic outcomes, underscoring his role as an important contributor to global scientific progress.

Profiles: Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

1. Ahmadi, M. H. (2021). Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control.

2. Farzi, S., Rezazadeh, M., Mirhosseini, A., Rezazadeh, M. A., Houshyar, F., & Ahmadi, M. H. (2021). Genetic diversity of healthcare-associated methicillin-resistant Staphylococcus aureus isolates from Southern Iran. Acta Microbiologica et Immunologica Hungarica.

3. Ahmadi, M. H. (2021). Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy.

4. Ahmadi, M. H. (2020). Indicated and non-indicated antibiotic administration during pregnancy and its effect on pregnancy outcomes: Role of inflammation. International Immunopharmacology.

5. Ahmadi, M. H. (2020). Frequency of antimicrobial resistance and class 1 and 2 integrons in Escherichia coli strains isolated from urinary tract infections. Iranian Journal of Pharmaceutical Research.